Cargando…
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
Solid organ transplant recipients are at high risk of severe coronavirus disease-2019 (COVID-19). If left untreated, it results in high rates of hospitalization, intensive care unit admission and death. Early diagnosis of COVID-19 is essential to ensure the early administration of therapeutics. Trea...
Autores principales: | Mendoza, Maria Alejandra, Razonable, Raymund R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028355/ https://www.ncbi.nlm.nih.gov/pubmed/37142512 http://dx.doi.org/10.1016/j.idc.2023.03.003 |
Ejemplares similares
-
Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update
por: Abad, Cybele L., et al.
Publicado: (2016) -
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
por: Ramanan, Poornima, et al.
Publicado: (2013) -
Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant
Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021) -
926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023) -
Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
por: Vergidis, Pascalis, et al.
Publicado: (2017)